Resources

This presentation was created by Ilze Kalnina, the Partner Engagement and Global Events Lead at the Partnership for Maternal, Newborn, and Child Health (PMNCH), and discusses how country efforts will be assessed by focusing on ensuring that there are better policies in place and to improve access to services by introducing the Collaborative Advocacy Action Plans Initiative (CAAP).

The presentation was given by Wanjiku Manguyu, a Regional Advocacy and Policy Advisor at PATH, and provides guidance for advocates and decision-makers on policy implementation.

Part 1 of "Tools for advancing maternal, newborn and child health (MNCH) advocacy and accountability from subnational to global levels," the second in our Africa regional MNCH advocacy dialogues series, was held on June 27, 2024, featuring a moderated discussion with panelists from PATH, Africa Health Budget Network, and the Partnership for Maternal, Newborn, and Child Health (PMNCH). The resources below include the presentations delivered by the panelists and recordings of the webinar in English and French.

PATH has taken a holistic approach to assessing the current anemia interventions at the national level and identifying the key strategies required to strengthen the national Anemia Mukt Bharat (AMB) program for effective implementation.We have undertaken a series of activities to achieve our objectives. These included a rapid assessment of 15 states in India to gain insights into the barriers and enablers of the AMB program implementation, the use of living labs with a human-centric research design to co-design solutions from the perspectives of health care workers, key informant interviews, state-level consultation workshops, and a comprehensive review of the different components of the AMB program to develop landscape documents and reports.Through these concerted efforts, we produced a plethora of knowledge products including a compendium of state-level case studies and best practices of anemia interventions, a living labs report, landscape documents focusing on digital interventions for anemia, anemia diagnostics, treatment pathways, market understanding of Injection ferric carboxymaltose, and IEC material.

Sickle cell disease (SCD) affects 7.74 million people globally, with a rising prevalence especially in low- and middle-income countries like India, where it ranks high among tribal populations.In Maharashtra, PATH, in collaboration with the state's public health department, is spearheading the National Sickle Cell Anemia Elimination Mission (NSCAEM). This brief outlines NSCAEM's comprehensive approach to tackling SCD, focusing on enhancing services and implementing innovative strategies in high-prevalence districts like Nandurbar and Gadchiroli.